¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"reticular lymphocyte"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
annular reticular fiber
°í¸®±×¹°¼¶À¯
intralaminar reticular nucleus
¼¶À¯ÆÇ¼Ó±×¹°ÇÙ, ÆÇ³»¸Á»óÇÙ
pontine tegmental reticular nucleus
´Ù¸®³úµÚÆÇ±×¹°ÇÙ, ±³³úÇǰ³¸Á»óÇÙ
paramedian reticular nucleus
Á¤Áß°ç±×¹°ÇÙ, Á¤Áß°ç¸Á»óÇÙ
reticular
±×¹°-, ¸Á»ó-
reticular acropigmentation
±×¹°¸»´Ü»ö¼ÒÄ§Âø
reticular atrophy
±×¹°À§Ãà, ¸Á»óÀ§Ãà
reticular cell
±×¹°¼¼Æ÷, ¸Á»ó¼¼Æ÷
reticular degeneration
±×¹°º¯¼º, ¸Á»óº¯¼º
reticular dermis
±×¹°ÁøÇÇ, ¸Á»óÁøÇÇ
reticular fiber
±×¹°¼¶À¯, ¸Á»ó¼¶À¯
reticular formation
±×¹°Ã¼, ¸Á»óü
reticular inhibitory area
±×¹°Ã¼¾ïÁ¦ºÎÀ§
reticular keratitis
±×¹°°¢¸·¿°
reticular lamina
±×¹°ÆÇ, ¸Á»óÆÇ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
mixed lymphocyte reaction
¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
mixed lymphocyte culture test
È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
monocyte lymphocyte ratio
´ÜÇÙ±¸¸²ÇÁ±¸ºñÀ²
primed lymphocyte typing
ÃÊȸÇ׿øÀÚ±ØÈĸ²ÇÁ±¸Çüº°È
primed lymphocyte-typing test
°¨ÀÛ¸²ÇÁ±¸Çüº°°Ë»ç
annular reticular fiber
µ¹¸²¼¼¸Á¼¶À¯
reticular acropigmentation
±×¹°¸»´Ü»ö¼ÒÄ§Âø
reticular anastomosis
±×¹°¿¬°á, ¸Á»ó¿¬°á
reticular atrophy
¸Á»óÀ§Ãà
reticular inhibitory area
±×¹°Ã¼¾ïÁ¦ºÎÀ§
reticular cell
±×¹°¼¼Æ÷
reticular degeneration
±×¹°º¯¼º
reticular density
¸Á»óÀ½¿µ, ±×¹°À½¿µ
reticular dermis
¸Á»óÁøÇÇ
reticular fiber
±×¹°¼¶À¯, ¸Á»ó¼¶À¯
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
10
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
T lymphocyte
T ¸²ÇÁ±¸
T-lymphocyte
T-Àӯı¸
anti-lymphocyte globulin
¸²ÇÁ±¸ Çױ۷κҸ°
antigen, lymphocyte defined (LD)
¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
granulocyte-monocyte-lymphocyte antigens
°ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
granulocyte-platelet-lymphocyte antigens
°ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
hodgkins disease,lymphocyte predominance
¸²ÇÁ±¸ ÇöÀúÇü
primed lymphocyte
ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸
primed lymphocyte typing
ÃÊȸÇ׿øÀÚ±ØÈÄ ¸²ÇÁ±¸Çüº°È
primed lymphocyte-typing test
ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸ÀÌ¿ë Çüº°°Ë»ç
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
lymphocyte
¸²ÇÁ±¸
lymphocyte activating factor
¸²ÇÁ±¸È°¼ºÀÎÀÚ
lymphocyte activating factor (LAF)
¸²ÇÁ±¸ Ȱ¼ºÈÀÎÀÚ
lymphocyte analysis
¸²ÇÁ±¸ºÐ¼®
lymphocyte culture, mixed
È¥ÇÕ ¸²ÇÁ±¸¹è¾ç
lymphocyte defined antigen
¸²ÇÁ±¸±ÔÁ¤Ç׿ø.
lymphocyte development
¸²ÇÁ±¸¹ßÀ°
lymphocyte dysfunction
¸²ÇÁ±¸±â´ÉÀå¾Ö<--ºÎÀü>
lymphocyte inhibitory factor (LIF)
¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
lymphocyte interaction
¸²ÇÁ±¸»óÈ£ÀÛ¿ë.
lymphocyte microcytotoxicity assay
¸²ÇÁ±¸¼Ò¼¼Æ÷µ¶¼º°Ë»ç
lymphocyte production
¸²ÇÁ±¸»ý¼º
lymphocyte proliferation
¸²ÇÁ±¸Áõ½Ä
lymphocyte transformation
¸²ÇÁ±¸Àüȯ(¡Ï¹ ï®üµ).
lymphocyte, resident
»óÁÖ¸²ÇÁ±¸
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½